Faculty profile

Lucie Germain

ResearcherChirurgieUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Lucie Germain

Researcher

Chirurgie

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
31 publications in the last five years, latest in 2026.
Senior (last) author on 20 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2024.
Supervisor on 11 trainee awards (11 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

115

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Culture Cutanée Différenciation Et Prolifération Des Cellules Cutanées Greffe Guérison Des Plaies Génie Tissulaire Crc Cellules Souches Peau

Latest papers

Reevaluating the declaration of sex in skin cell studies.
The Journal of investigative dermatology · 2026 · senior author
De novo formation of human sebaceous glands using self-assembled skin substitutes.
The Journal of investigative dermatology · 2026 · senior author
Factors affecting skin keratinocyte and fibroblast extraction yields for the production of living skin substitutes to treat severely burned patients.
Burns : journal of the International Society for Burn Injuries · 2026 · senior author

All 115 publications

Latest funding

Améliorer la pigmentation des peaux reconstruites bilamellaires
CIHR · 2026 · Supervisor
$6,000
GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease
CIHR · 2024 · Nominated PI
$1,137,500
Real World Clinical and Economic Burden of Severe Burn Injuries
CIHR · 2023 · Co-investigator
$221,850

All 29 grants and awards

115 publications.

Reevaluating the declaration of sex in skin cell studies.

Celac I, Nguyen BT, Larouche D, Mainville L, Germain L

The Journal of investigative dermatology2026Senior author

DOI: 10.1016/j.jid.2026.01.028 PMID: 41654167

De novo formation of human sebaceous glands using self-assembled skin substitutes.

Magne B, Cattier B, Lemire-Rondeau M, Morissette A, Larouche D, Philippe É, Germain L

The Journal of investigative dermatology2026Senior author

DOI: 10.1016/j.jid.2026.03.021 PMID: 41933878

Factors affecting skin keratinocyte and fibroblast extraction yields for the production of living skin substitutes to treat severely burned patients.

Dubourget L, Larouche D, Ghio SC, Moulin VJ, Beaudoin-Cloutier C, Germain L

Burns : journal of the International Society for Burn Injuries2026Senior author

DOI: 10.1016/j.burns.2025.107805 PMID: 41453337

Initiating Separate Cultures of Keratinocytes and Melanocytes from a Single Biopsy.

Ferland K, De Koninck H, Cattier B, Cortez Ghio S, Larouche D, Germain L

Methods in molecular biology (Clifton, N.J.)2025Senior author

DOI: 10.1007/978-1-0716-4510-9_3 PMID: 40208525

Culture Strategy Determines the Differentiation Status of Sweat Gland Cells.

De Koninck H, Ferland K, Barbier MA, Larouche D, Germain L

Cells2025Senior author

DOI: 10.3390/cells14201643 PMID: 41148857

Bulge-Derived Epithelial Cells Isolated from Human Hair Follicles Using Enzymatic Digestion or Explants Result in Comparable Tissue-Engineered Skin.

Cattier B, Guignard R, Martel I, Martel C, Simard-Bisson C, Larouche D, Guiraud B, Bessou-Touya S, Germain L

International journal of molecular sciences2025Senior author

DOI: 10.3390/ijms26051852 PMID: 40076477

Effect of Fibroblast Growth Factor-2 on Melanocyte Proliferation in Tissue-Engineered Skin Substitutes.

Ferland K, Magne B, De Koninck H, Barbier MA, Larouche D, Germain L

International journal of molecular sciences2025Senior author

DOI: 10.3390/ijms26041704 PMID: 40004167

The Human Neonatal Skin Fibroblast, an Available Cell Source for Tissue Production and Transplantation, Exhibits Low Risk of Immunogenicity In Vitro.

Magne B, Ferland K, Savard É, Barbier MA, Morissette A, Larouche D, Beaudoin-Cloutier C, Germain L

International journal of molecular sciences2024Senior author

DOI: 10.3390/ijms25136965 PMID: 39000078

Balancing act: optimizing blue light for melanogenesis while minimizing cellular damage in primary human skin cells.

Barolet AC, Magne B, Ferland K, Uzunbajakava NE, Barolet D, Germain L

Frontiers in physiology2024Senior author

DOI: 10.3389/fphys.2024.1513054 PMID: 39850449

Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ).

Espinoza-Moya ME, Laberge M, Bélanger L, Chang SL, Poder TG, Moulin VJ, Germain L, Beaudoin Cloutier C, Guertin JR

Burns : journal of the International Society for Burn Injuries2024

DOI: 10.1016/j.burns.2024.07.008 PMID: 39322506

Améliorer la pigmentation des peaux reconstruites bilamellaires

SupervisorCIHR2026Undergraduate Student Research Awards (USRA)

Principal investigators: Nkuindja, Djomou-Laetitia

Keywords: Cellules Épithéliales; Génie Tissulaire; Peaux Reconstruites Bilamellaires

$6,000

GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease

Nominated PICIHR2024Operating Grant:Bringing Rare Disease Gene Therapies to Clinical Trial Readiness

Principal investigators: Germain, Lucie; Pope, Elena; Caruso, Manuel P; Fradette, Julie; Guertin, Jason R; Laprise, Catherine; Laurin, Mélanie; Zawati, Ma'n Hilmi M.

Keywords: Collagen; Epidermolysis Bullosa; Gene Therapy; Novel Treatment; Pediatric Disease; Rare Disease; Skin Genetic Disease; Skin Grafting; Stem Cells, Skin; Tissue Engineering

$1,137,500

Real World Clinical and Economic Burden of Severe Burn Injuries

Co-investigatorCIHR2023Project Grant

Principal investigators: Guertin, Jason R; Beaudoin Cloutier, Chanel

Keywords: Burn Injuries; Cost Evaluations; Health Administrative Data; Observational Studies; Retrospective Studies

$221,850

Étude des mécanismes cellulaires et moléculaires modulant l'expression du gène de la CLUSTERINE durant la fermeture des plaies cornéennes humaines.

SupervisorCIHR2023CIHR Fellowship

Principal investigators: Gross, Christelle

Keywords: Cicatrisation; Cornée Humaine Reconstruite; Génie Tissulaire; Matrice Extracellulaire; Régulation De L'Expression Génique; Transcription

$150,000

Urogenital tissue engineering solutions for transgender surgeries

Co-investigatorSSHRC2023New Frontiers in Research Fund - Exploration

Principal investigators: Bolduc, Stéphane

Keywords: urethra; vagina; tissue engineering; cell culture; epithelial cells; fibroblasts; urothelial cells; estrogen; extracellular matrix; self-assembly method

$250,000

A human tissue-engineered three-layer cornea (hTEC) supplemented with macrophages as a biomaterial for in vitro studies

Co-investigatorCIHR2023Project Grant

Principal investigators: Guerin, Sylvain L

Keywords: Biomaterial; Clusterin Gene; Corneal Wound Healing; Human Corneal Endothelial Cells; Human Corneal Epithelial Cells; Human Corneal Stromal Stem Cells; Human Immune Cells; Signal Transduction Pathways; Tissue Engineered Human Cornea

$864,450

Régénération de la peau humaine : Une peau reconstruite par génie tissulaire pigmentée produite plus rapidement pour traiter les patients grands brûlés

Nominated PICIHR2021Project Grant

Principal investigators: Germain, Lucie

Keywords: Cellules Souches De Peau; Culture Cutanée; Différenciation Et Prolifération Des Cellules Cutanées; Greffe; Guérison Des Plaies; Génie Tissulaire; Réactions Immunitaires Et Rejet De Greffe

$753,370

Tissue-engineered solutions for uro-genital reconstruction, and replacing banned synthetic meshes.

Co-investigatorCIHR2021Project Grant

Principal investigators: Bolduc, Stéphane

Keywords: Animal Model; Bioreactor; Cell Culture; Epithelial Cells; Extracellular Matrix; Fibroblasts; Mechanical Resistance; Reconstruction; Tissue Engineering; Vagina

$868,276

Canada Reseach Chair - Tier 1

Nominated PICIHR2021Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Germain, Lucie

Keywords: Crc

$1,400,000

Tissue-engineered solutions for uro-genital reconstruction, and replacing banned synthetic meshes.

Co-investigatorCIHR2020Project Grant - PA: Sex and Gender in Health Research (Bridge funding)

Principal investigators: Bolduc, Stéphane

Keywords: Animal Model; Bioreactor; Cell Culture; Epithelial Cells; Extracellular Matrix; Fibroblasts; Mechanical Resistance; Reconstruction; Tissue Engineering; Vagina

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Lucie Germain

Research

Latest papers

Latest funding

Reevaluating the declaration of sex in skin cell studies.

De novo formation of human sebaceous glands using self-assembled skin substitutes.

Factors affecting skin keratinocyte and fibroblast extraction yields for the production of living skin substitutes to treat severely burned patients.

Initiating Separate Cultures of Keratinocytes and Melanocytes from a Single Biopsy.

Culture Strategy Determines the Differentiation Status of Sweat Gland Cells.

Bulge-Derived Epithelial Cells Isolated from Human Hair Follicles Using Enzymatic Digestion or Explants Result in Comparable Tissue-Engineered Skin.

Effect of Fibroblast Growth Factor-2 on Melanocyte Proliferation in Tissue-Engineered Skin Substitutes.

The Human Neonatal Skin Fibroblast, an Available Cell Source for Tissue Production and Transplantation, Exhibits Low Risk of Immunogenicity In Vitro.

Balancing act: optimizing blue light for melanogenesis while minimizing cellular damage in primary human skin cells.

Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ).

Urogenital tissue engineering solutions for transgender surgeries

Frequent collaborators

Julie Fradette

Ze Zhang

Chanel Beaudoin Cloutier

Solange Landreville

Manuel Caruso

Charles Morin

Maude Laberge

Ivan Litvinov

Vincent Piguet

Véronique Moulin

Robert Gniadecki

Rachael Manion

Catherine Laprise

Catherine Laprise

Anie Philip

Roxane Pouliot

An-Wen Chan

Sarvesh Logsetty

Jan Dutz

Morris Manolson

Youwen Zhou